Eli Lilly Analyst Price Targets

Eli Lilly and Co

LLYNYSE

$1162.49

5.760.5%

最終更新: Sep 1, 1:45 PM

M&A: Merida Biosciences, Inc. announced it will be acquired by Eli Lilly (LLY) on Monday, August 31, 2026 for $2.9B paid in cash

Wall Street analyst price targets and consensus rating for Eli Lilly (LLY).

Price Target Range — 9 Quarters

Analyst Consensus — 20 Analysts

19Buy

1Hold

Consensus RatingBuy# Analysts20Avg. Consensus PT$1237Upside to Avg. PT+6.4%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 7, 2026	Truist Securities	Robyn Karnauskas	PT Raise	Buy	$1370→$1376
Aug 6, 2026	Wells Fargo	Mohit Bansal	PT Raise	Overweight	$1280→$1330
Aug 6, 2026	Cantor Fitzgerald	Carter Gould	PT Raise	Overweight	$1350→$1410
Jul 15, 2026	Citigroup	Geoff Meacham	PT Raise	Buy	$1500→$1600
Jul 14, 2026	Bernstein	Courtney Breen	PT Raise	Outperform	$1300→$1385
Jul 13, 2026	UBS	Michael Yee	PT Raise	Buy	$1250→$1425
Jul 13, 2026	Guggenheim	Seamus Fernandez	PT Cut	Buy	$1235→$1273
Jul 10, 2026	B of A Securities	Jason Gerberry	PT Raise	Buy	$1251→$1334
Jul 8, 2026	Truist Securities	Robyn Karnauskas	PT Raise	Buy	$1281→$1370
Jul 8, 2026	Morgan Stanley	Terence Flynn	PT Raise	Overweight	$1344→$1347
Jul 8, 2026	RBC Capital	Trung Huynh	PT Raise	Outperform	$1250→$1500
Jul 7, 2026	JP Morgan	Chris Schott	PT Raise	Overweight	$1300→$1400
Jul 6, 2026	Cantor Fitzgerald	Carter Gould	PT Raise	Overweight	$1230→$1350
Jun 25, 2026	Leerink Partners	David Risinger	PT Raise	Outperform	$1119→$1232
Jun 9, 2026	Jefferies	Akash Tewari	PT Raise	Buy	$1330→$1350
May 26, 2026	B of A Securities	Jason Gerberry	PT Raise	Buy	$1133→$1251
May 5, 2026	Barclays	Emily Field	PT Raise	Overweight	$1350→$1400
May 5, 2026	Guggenheim	Seamus Fernandez	Maintained	Buy	$1183
May 4, 2026	Wolfe Research	Alexandria Hammond	Maintained	Outperform	$1325
May 1, 2026	Cantor Fitzgerald	Carter Gould	PT Raise	Overweight	$1205→$1230